Are you unsure about some of the terminology used by specialists who are preparing your evidence dossier? Here our experts answer some of the most frequently asked questions about systematic literature reviews and network meta-analysis.
What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
Alex Hodkinson recently joined Mtech Access as Consultant – Statistician in our evidence synthesis team. In this interview, we learn about his career to date and what inspired him to join Mtech Access. Alex also shares some of his experiences since joining the team.
What’s involved in conducting a systematic review? Our evidence experts outline the 7 stages for developing a HTA-ready gold-standard systematic literature review.
Hayley Shoel shares her experience of joining Mtech Access’ specialist medical writing team. Explore the different types of projects she’s working on. Discover what you could expect if you joined us at Mtech Access.
Rachel Hibbs (Consultant – Systematic Review) tells us about her career to date and what inspired her to join Mtech Access.
We bring together specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024-25. Jump in, as our experts give their hot-take on each trend, sharing their perspectives on what’s happening in these areas.
Discover 11 common problems that may arise when cost-cutting compromises the quality of your systematic literature review.
What actions can you take in light of ISPOR’s top 10 HEOR trends? What impact may these issues have on your HEOR and Market Access strategy?